Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Myeloproliferative Disorders × Blood Specimen Collection × Clear all

Status

Unknown 2 Recruiting 2 Enrolling by invitation 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 46 Neoplasms 31 Colorectal Neoplasms 23 Melanoma 15 Prostatic Neoplasms 13 Neoplastic Cells, Circulating 12 Lung Neoplasms 12 Multiple Myeloma 11 Pancreatic Neoplasms 10 Ovarian Neoplasms 9 Uterine Cervical Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Colonic Neoplasms 7 Papillomavirus Infections 6 Neoplasm Metastasis 6 Lymphoma 6 Leukemia, Myeloid, Acute 6 Hematologic Neoplasms 6 Uveal Melanoma 5 Head and Neck Neoplasms 5 Glioma 5 Sarcoma 4 Glioblastoma 4 Disease 4 COVID-19 4 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Plasma Cell 3

Interventions

fludarabine phosphate 50 Cyclophosphamide 47 Peripheral Blood Stem Cell Transplantation 39 Mycophenolic Acid 32 Busulfan 31 Whole-Body Irradiation 28 Tacrolimus 27 Cyclosporine 27 Antilymphocyte Serum 27 Filgrastim 24 Methotrexate 19 Cytarabine 18 fludarabine 16 Etoposide 16 Radiotherapy 15 Melphalan 15 Methylprednisolone 12 ruxolitinib 11 thymoglobulin 8 Sirolimus 8 Psychiatric Rehabilitation 8 Flow Cytometry 8 Cyclosporins 8 Alemtuzumab 8 Granulocyte Colony-Stimulating Factor 7 Decitabine 7 Cord Blood Stem Cell Transplantation 7 Azacitidine 7 Daunorubicin 6 sargramostim 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02862366 2018-10-31

MICROP-SMP

Lille Catholic University

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡